Alveogene
Inhaled gene therapy development for patients with rare respiratory diseases
Highlights
- Young companyFounded 2022
- New on EvolcAdded 2026-11-11
About Alveogene
AlveoGene develops inhaled gene therapies for serious respiratory diseases using its InGenuiTy platform, a licensed lentiviral delivery platform intended to target lung cells. Therapies can be delivered by nebuliser or, for neonates, through endotracheal tubing.
The company was created by Oxford Science Enterprises, Harrington Discovery Institute, Old College Capital and six scientists from the UK Respiratory Gene Therapy Consortium. It holds an exclusive licence to the platform for respiratory diseases, excluding use of the CFTR gene.
Product: Development of inhaled lentiviral gene therapies for serious respiratory diseases using the InGenuiTy platform.
Jobs at Alveogene
Leadership
- Christopher Boyd · DrSource: company website
- Deborah Gill · ProfessorSource: company website
- Eric Alton · ProfessorSource: company website
- Gerry McLachlan · DrSource: company website
- Stephen Hyde · ProfessorSource: company website
- Uta Griesenbach · ProfessorSource: company website
More biotech & pharma companies
Amaxa
Pharmaceutical company supplying prescription and OTC medicines to specialist markets across Europe, Central Asia and the Middle EastAmgen
Biotechnology company developing and manufacturing biologic medicines for serious illnesses, with UK sites in Cambridge and UxbridgeAminoanalytica
AI-enabled, field-ready diagnostics for emerging biological threats, supporting earlier pandemic detection and responseYoung companyNew on EvolcAmo Pharma
Develops investigational treatments for serious diseases, particularly rare genetic disorders, for patients with unmet medical needsNew on EvolcAmped PCR
QPCR reagents and custom formulations for research labs, assay developers and molecular testing partnersYoung companyNew on EvolcAmphista Therapeutics
Targeted protein degradation drug developer building Targeted Glue degraders for oncology, led by AMX-883 for AML
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
